A diabetic woman almost died from the “world’s most dangerous eating disorder” after doctors mistook her insulin misuse for ...

Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, ...

Cipla receives approval to market Afrezza, a rapid-acting insulin inhaler, offering a needle-free solution for diabetes ...

Cipla received approval from CDSCO to distribute and market Afrezza, an inhalable insulin, in India. Developed by MannKind, ...

This is the first and only non- injectable insulin to be developed for patients of both type 1 and type 2 diabetes mellitus.

It is a disease which cannot be cured, only managed - an autoimmune condition, meaning that the body’s defence system attacks ...

Indian regulator Central Drugs Standard Control Organisation (CDSCO) has approved Cipla to exclusively distribute and market ...

Sol-Millennium® Medical Group, a leading manufacturer of medical devices, has launched an innovative needle-free injection ...

Taken at the beginning of a meal, the medication dissolves rapidly upon oral inhalation into the lungs and delivers insulin ...

Cipla to introduce Afrezza, an inhaled insulin for diabetes, offering convenience but not advised for lung-related concerns.

Drug maker Cipla on Wednesday said it has received approval from the Central Drugs Standard Control Organisation for the ...

"Well, it took you long enough!" Those were the words of William Dale Archerd when police finally knocked on his door in 1968 ...